An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta
Clinical trial NCT03216486 · WITHDRAWN
Trial details
- NCT number
- NCT03216486
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2018-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.